Literature DB >> 27030269

Trimer Enhancement Mutation Effects on HIV-1 Matrix Protein Binding Activities.

Ayna Alfadhli1, Andrew Mack1, Christopher Ritchie1, Isabel Cylinder1, Logan Harper1, Philip R Tedbury2, Eric O Freed2, Eric Barklis3.   

Abstract

UNLABELLED: The HIV-1 matrix (MA) protein is the amino-terminal domain of the HIV-1 precursor Gag (Pr55Gag) protein. MA binds to membranes and RNAs, helps transport Pr55Gag proteins to virus assembly sites at the plasma membranes of infected cells, and facilitates the incorporation of HIV-1 envelope (Env) proteins into virions by virtue of an interaction with the Env protein cytoplasmic tails (CTs). MA has been shown to crystallize as a trimer and to organize on membranes in hexamer lattices. MA mutations that localize to residues near the ends of trimer spokes have been observed to impair Env protein assembly into virus particles, and several of these are suppressed by the 62QR mutation at the hubs of trimer interfaces. We have examined the binding activities of wild-type (WT) MA and 62QR MA variants and found that the 62QR mutation stabilized MA trimers but did not alter the way MA proteins organized on membranes. Relative to WT MA, the 62QR protein showed small effects on membrane and RNA binding. However, 62QR proteins bound significantly better to Env CTs than their WT counterparts, and CT binding efficiencies correlated with trimerization efficiencies. Our data suggest a model in which multivalent binding of trimeric HIV-1 Env proteins to MA trimers contributes to the process of Env virion incorporation. IMPORTANCE: The HIV-1 Env proteins assemble as trimers, and incorporation of the proteins into virus particles requires an interaction of Env CT domains with the MA domains of the viral precursor Gag proteins. Despite this knowledge, little is known about the mechanisms by which MA facilitates the virion incorporation of Env proteins. To help elucidate this process, we examined the binding activities of an MA mutant that stabilizes MA trimers. We found that the mutant proteins organized similarly to WT proteins on membranes, and that mutant and WT proteins revealed only slight differences in their binding to RNAs or lipids. However, the mutant proteins showed better binding to Env CTs than the WT proteins, and CT binding correlated with MA trimerization. Our results suggest that multivalent binding of trimeric HIV-1 Env proteins to MA trimers contributes to the process of Env virion incorporation.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27030269      PMCID: PMC4886772          DOI: 10.1128/JVI.00509-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Plasma membrane rafts play a critical role in HIV-1 assembly and release.

Authors:  A Ono; E O Freed
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

2.  Hydroxyl radical mediated damage to proteins, with special reference to the crystallins.

Authors:  P Guptasarma; D Balasubramanian; S Matsugo; I Saito
Journal:  Biochemistry       Date:  1992-05-05       Impact factor: 3.162

3.  A tyrosine-based motif in the HIV-1 envelope glycoprotein tail mediates cell-type- and Rab11-FIP1C-dependent incorporation into virions.

Authors:  Mingli Qi; Hin Chu; Xuemin Chen; Junghwa Choi; Xiaoyun Wen; Jason Hammonds; Lingmei Ding; Eric Hunter; Paul Spearman
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-01       Impact factor: 11.205

4.  Evidence in support of RNA-mediated inhibition of phosphatidylserine-dependent HIV-1 Gag membrane binding in cells.

Authors:  Vineela Chukkapalli; Jingga Inlora; Gabrielle C Todd; Akira Ono
Journal:  J Virol       Date:  2013-04-03       Impact factor: 5.103

5.  Direct interaction between the envelope and matrix proteins of HIV-1.

Authors:  P Cosson
Journal:  EMBO J       Date:  1996-11-01       Impact factor: 11.598

6.  Sequence-specific interaction between HIV-1 matrix protein and viral genomic RNA revealed by in vitro genetic selection.

Authors:  P Purohit; S Dupont; M Stevenson; M R Green
Journal:  RNA       Date:  2001-04       Impact factor: 4.942

7.  Analysis of human immunodeficiency virus type 1 matrix binding to membranes and nucleic acids.

Authors:  Ayna Alfadhli; Amelia Still; Eric Barklis
Journal:  J Virol       Date:  2009-09-23       Impact factor: 5.103

8.  Opposing mechanisms involving RNA and lipids regulate HIV-1 Gag membrane binding through the highly basic region of the matrix domain.

Authors:  Vineela Chukkapalli; Seung J Oh; Akira Ono
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

9.  Maturation-dependent HIV-1 surface protein redistribution revealed by fluorescence nanoscopy.

Authors:  Jakub Chojnacki; Thorsten Staudt; Bärbel Glass; Pit Bingen; Johann Engelhardt; Maria Anders; Jale Schneider; Barbara Müller; Stefan W Hell; Hans-Georg Kräusslich
Journal:  Science       Date:  2012-10-26       Impact factor: 47.728

10.  Membrane binding and subcellular localization of retroviral Gag proteins are differentially regulated by MA interactions with phosphatidylinositol-(4,5)-bisphosphate and RNA.

Authors:  Jingga Inlora; David R Collins; Marc E Trubin; Ji Yeon J Chung; Akira Ono
Journal:  MBio       Date:  2014-12-09       Impact factor: 7.867

View more
  17 in total

1.  HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.

Authors:  Philip R Tedbury; Mariia Novikova; Ayna Alfadhli; Yuta Hikichi; Ioannis Kagiampakis; Vineet N KewalRamani; Eric Barklis; Eric O Freed
Journal:  J Virol       Date:  2019-12-12       Impact factor: 5.103

2.  Replication of HIV-1 envelope protein cytoplasmic domain variants in permissive and restrictive cells.

Authors:  August O Staubus; Ayna Alfadhli; Robin Lid Barklis; Eric Barklis
Journal:  Virology       Date:  2019-09-18       Impact factor: 3.616

3.  Distinct functions for the membrane-proximal ectodomain region (MPER) of HIV-1 gp41 in cell-free and cell-cell viral transmission and cell-cell fusion.

Authors:  Vani G S Narasimhulu; Anna K Bellamy-McIntyre; Annamarie E Laumaea; Chan-Sien Lay; David N Harrison; Hannah A D King; Heidi E Drummer; Pantelis Poumbourios
Journal:  J Biol Chem       Date:  2018-03-01       Impact factor: 5.157

4.  Structural and biophysical characterizations of HIV-1 matrix trimer binding to lipid nanodiscs shed light on virus assembly.

Authors:  R Elliot Murphy; Alexandra B Samal; Jiri Vlach; Vicente Mas; Peter E Prevelige; Jamil S Saad
Journal:  J Biol Chem       Date:  2019-10-22       Impact factor: 5.157

5.  Organization of Farnesylated, Carboxymethylated KRAS4B on Membranes.

Authors:  Eric Barklis; Andrew G Stephen; August O Staubus; Robin Lid Barklis; Ayna Alfadhli
Journal:  J Mol Biol       Date:  2019-07-19       Impact factor: 5.469

6.  Analysis of quinolinequinone reactivity, cytotoxicity, and anti-HIV-1 properties.

Authors:  Ayna Alfadhli; Andrew Mack; Logan Harper; Sam Berk; Christopher Ritchie; Eric Barklis
Journal:  Bioorg Med Chem       Date:  2016-09-12       Impact factor: 3.641

7.  Analysis of HIV-1 Matrix-Envelope Cytoplasmic Tail Interactions.

Authors:  Ayna Alfadhli; August O Staubus; Philip R Tedbury; Mariia Novikova; Eric O Freed; Eric Barklis
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

8.  Interaction Interface of Mason-Pfizer Monkey Virus Matrix and Envelope Proteins.

Authors:  Jan Prchal; Jakub Sýs; Petra Junková; Jan Lipov; Tomáš Ruml
Journal:  J Virol       Date:  2020-09-29       Impact factor: 5.103

9.  HIV-1 matrix-tRNA complex structure reveals basis for host control of Gag localization.

Authors:  Charles Bou-Nader; Frauke Muecksch; Janae B Brown; Jackson M Gordon; Ashley York; Chen Peng; Rodolfo Ghirlando; Michael F Summers; Paul D Bieniasz; Jinwei Zhang
Journal:  Cell Host Microbe       Date:  2021-08-11       Impact factor: 31.316

10.  Capsid-specific nanobody effects on HIV-1 assembly and infectivity.

Authors:  Ayna Alfadhli; CeAnn Romanaggi; Robin Lid Barklis; Ilaria Merutka; Timothy A Bates; Fikadu G Tafesse; Eric Barklis
Journal:  Virology       Date:  2021-07-05       Impact factor: 3.513

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.